Suppr超能文献

Incidence of hypertrophic scars among African Americans linked to vitamin D-3 metabolism?

作者信息

Cooke Gerald L, Chien Anna, Brodsky Amy, Lee Raphael C

机构信息

Department of Surgery, Medicine and Organismal Biology & Anatomy, Pritzker School of Medicine, The University of Chicago, Chicago, IL 60637, USA.

出版信息

J Natl Med Assoc. 2005 Jul;97(7):1004-9.

Abstract

The pathogenesis and progression of wound-healing involve intricate pathways and numerous chemical mediators. This remains an area of intense study as undesirable results of this process, such as hypertrophic scars and keloids, can result in significant morbidity. These lesions are distinct in their characteristics, although they are similar in their distribution in patients with darker skin colors. There is a robust inflammatory mechanism behind the formation of hypertrophic scars and keloids. Furthermore, their development may be intimately related to vitamin D-3, which has been shown to be a powerful anti-inflammatory agent. This chemical is made in the skin, whose production is influenced by various factors of which the amount of melanin is a crucial one. More specifically, an increase in pigmentation has been shown to decrease the amount of vitamin D-3 synthesis in the skin. Thus, this paper proposes the hypothesis linking the propensity of inflammation and subsequent scarring in darker-skinned individuals to the reduced levels of vitamin D-3 production in their skin.

摘要

相似文献

3
New insights on keloids, hypertrophic scars, and striae.
Dermatol Clin. 2014 Apr;32(2):193-209. doi: 10.1016/j.det.2013.11.002.
4
Mechanobiology and force transduction in scars developed in darker skin types.
Skin Res Technol. 2006 Nov;12(4):279-82. doi: 10.1111/j.0909-752X.2006.00165.x.
7
Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
Int J Mol Sci. 2017 Mar 10;18(3):606. doi: 10.3390/ijms18030606.
8
Keloids and hypertrophic scars: are they two different sides of the same coin?
Dermatol Surg. 2008 Mar;34(3):336-46. doi: 10.1111/j.1524-4725.2007.34067.x. Epub 2007 Dec 19.
9
Keloids and ultrasound detected fibroids in young African American women.
PLoS One. 2013 Dec 27;8(12):e84737. doi: 10.1371/journal.pone.0084737. eCollection 2013.
10
Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management.
Dermatol Surg. 2009 Feb;35(2):171-81. doi: 10.1111/j.1524-4725.2008.34406.x.

引用本文的文献

2
Evidence-Based Topical Therapy for Facial Scars in Diverse Skin Types.
Cureus. 2025 Jun 19;17(6):e86343. doi: 10.7759/cureus.86343. eCollection 2025 Jun.
3
Pharmacotherapy for Keloids and Hypertrophic Scars.
Int J Mol Sci. 2024 Apr 25;25(9):4674. doi: 10.3390/ijms25094674.
4
In-depth examination of hyperproliferative healing in two breeds of commonly used for research.
Animal Model Exp Med. 2021 Nov 22;4(4):406-417. doi: 10.1002/ame2.12188. eCollection 2021 Dec.
5
Vitamin D Clinical Pharmacology: Relevance to COVID-19 Pathogenesis.
J Natl Med Assoc. 2021 Apr;113(2):208-211. doi: 10.1016/j.jnma.2020.09.152. Epub 2020 Nov 2.
6
The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models.
Front Cell Dev Biol. 2020 May 26;8:360. doi: 10.3389/fcell.2020.00360. eCollection 2020.
7
High-mobility Group Box Protein-1, Matrix Metalloproteinases, and Vitamin D in Keloids and Hypertrophic Scars.
Plast Reconstr Surg Glob Open. 2015 Jul 8;3(6):e425. doi: 10.1097/GOX.0000000000000391. eCollection 2015 Jun.

本文引用的文献

1
From scarless fetal wounds to keloids: molecular studies in wound healing.
Wound Repair Regen. 2003 Nov-Dec;11(6):411-8. doi: 10.1046/j.1524-475x.2003.11604.x.
4
Confocal microscopic analysis of scarless repair in the fetal rat: defining the transition.
Plast Reconstr Surg. 2002 Jan;109(1):160-70. doi: 10.1097/00006534-200201000-00026.
8
Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair.
Cytokine. 2000 Jun;12(6):671-6. doi: 10.1006/cyto.1999.0598.
9
Elevated interleukin-6 expression in keloid fibroblasts.
J Surg Res. 2000 Mar;89(1):74-7. doi: 10.1006/jsre.1999.5805.
10
Treatment of linear scleroderma with oral 1,25-dihydroxyvitamin D3 (calcitriol) in seven children.
Pediatr Dermatol. 1999 Jan-Feb;16(1):53-8. doi: 10.1046/j.1525-1470.1999.99016.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验